{"id":51649,"date":"2026-10-05T05:00:00","date_gmt":"2026-10-05T09:00:00","guid":{"rendered":"https:\/\/vibefarma.com\/us\/?p=51649"},"modified":"2026-09-25T16:09:24","modified_gmt":"2026-09-25T20:09:24","slug":"inflammation-that-never-resolves","status":"publish","type":"post","link":"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/","title":{"rendered":"Why does some inflammation never fully resolve?"},"content":{"rendered":"<style>.vf-post h2{color:#004B53;font-weight:800;font-size:1.7em;line-height:1.25;margin-top:2.2em!important;margin-bottom:.65em!important;padding-bottom:10px;border-bottom:2px solid #d7ebe9;}.vf-post h3{color:#10302B;font-weight:700;font-size:1.15em;margin-top:2em!important;margin-bottom:.45em!important;}.vf-post .vf-tldr{background:#F8FDFF;border-left:4px solid #258055;padding:14px 18px;border-radius:6px;margin:18px 0;}.vf-post .vf-note{background:#eef7ef;border-left:4px solid #258055;padding:13px 17px;border-radius:6px;margin:16px 0;}.vf-post .vf-warn{background:#fff7ed;border-left:4px solid #F96E50;padding:14px 18px;border-radius:6px;margin:18px 0;}.vf-post .vf-step{background:#F8FDFF;border:1px solid #d7ebe9;border-radius:10px;padding:16px 20px;margin:14px 0;}.vf-post .vf-step strong{color:#004B53;}.vf-post > p{margin:0 0 1.5em!important;}.vf-post > ol,.vf-post > ul{margin:0 0 1.7em!important;}.vf-post > ol > li,.vf-post > ul > li{margin:0 0 .55em!important;}.vf-post sup a{text-decoration:none;color:#258055;}.vf-post img{max-width:100%;height:auto;}<\/style>\n<div class=\"vf-post\">\n<p class=\"post-byline\" style=\"color:#666;\"><em>Written by Toni Villar \u00b7 Medically reviewed by Dr. Jorge Oseguera Anguiano, functional and pro-resolution medicine \u00b7 Updated October 2026<\/em><\/p>\n<div class=\"vf-tldr\">\n<p style=\"margin:0;\"><strong>The short version:<\/strong> inflammation that lingers usually isn&#8217;t inflammation that&#8217;s too strong. It&#8217;s a shutdown that falls short. Your body doesn&#8217;t turn inflammation off by waiting for it to burn out: it closes it with a program of its own, and that program can stall halfway. A London lab has timed it in healthy people, by triggering a small, controlled inflammation in the skin: faced with the same trigger, some people close it early and others late, and with age the switch-on stays the same while the shutdown gets slower. Three things decide the shutdown: the machinery that clears up, the raw material your body builds its resolution signals from \u2014omega-3\u2014 and the conditions you live in. <strong>Looking after all three adds a layer to whatever you&#8217;re already doing: helping your body finish what it started.<\/strong><\/p>\n<\/div>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_88 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Contenido<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Is_inflammation_that_wont_go_away_just_%E2%80%9Ctoo_strong%E2%80%9D\" >Is inflammation that won&#8217;t go away just &#8220;too strong&#8221;?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Can_you_actually_see_whether_someones_body_closes_inflammation_well\" >Can you actually see whether someone&#8217;s body closes inflammation well?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Why_does_the_body_sometimes_not_finish_the_job\" >Why does the body sometimes not finish the job?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#What_about_anti-inflammatories\" >What about anti-inflammatories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#What_happens_when_you_give_your_body_the_raw_material\" >What happens when you give your body the raw material?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Does_this_replace_what_Im_already_doing\" >Does this replace what I&#8217;m already doing?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Where_to_start\" >Where to start<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Frequently_asked_questions\" >Frequently asked questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Why_does_inflammation_sometimes_not_resolve\" >Why does inflammation sometimes not resolve?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Does_everyone_resolve_inflammation_the_same_way\" >Does everyone resolve inflammation the same way?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#What_does_the_body_need_to_close_an_inflammatory_response\" >What does the body need to close an inflammatory response?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Do_anti-inflammatories_help_close_inflammation\" >Do anti-inflammatories help close inflammation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#Does_taking_omega-3_change_anything_quickly\" >Does taking omega-3 change anything quickly?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#References\" >References<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Is_inflammation_that_wont_go_away_just_%E2%80%9Ctoo_strong%E2%80%9D\"><\/span>Is inflammation that won&#8217;t go away just &#8220;too strong&#8221;?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Not necessarily. What won&#8217;t go away is what hasn&#8217;t been closed, and that&#8217;s a different thing.<\/strong><\/p>\n<p>Intuition says that if something is still inflamed, there must be a lot of fire. Carl Nathan and Aihao Ding put it another way in <em>Cell<\/em>: apart from whatever triggered it still being there, <strong>inflammation stays unresolved when the mechanisms that should close it fall short<\/strong>. And that can happen whether the response starts off excessive or starts off <strong>weaker than normal<\/strong><sup><a href=\"#referencias\">1<\/a><\/sup>.<\/p>\n<p>In healthy volunteers, <strong>the people who became most inflamed at the start were the ones who cleared their inflammatory cells fastest<\/strong> at the end<sup><a href=\"#referencias\">2<\/a><\/sup>. Switching on hard wasn&#8217;t the problem. For them, it was part of closing well.<\/p>\n<p>If you want the closing process step by step, it&#8217;s in <a href=\"https:\/\/vibefarma.com\/us\/blog\/what-is-resolution-of-inflammation\/\">what resolution of inflammation is<\/a>. Here we go to what goes wrong.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Can_you_actually_see_whether_someones_body_closes_inflammation_well\"><\/span>Can you actually see whether someone&#8217;s body closes inflammation well?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Yes. The shutdown of an inflammatory response can be timed in people, and not everyone closes it the same way.<\/strong><\/p>\n<p>There are lab models built precisely for that: in healthy volunteers, a small, controlled inflammation is triggered in the skin of the forearm \u2014a tiny blister, or bacteria that are already dead and can&#8217;t infect\u2014 and researchers follow hour by hour which cells arrive, when they leave and what signals they make<sup><a href=\"#referencias\">2<\/a><\/sup><sup><a href=\"#referencias\">3<\/a><\/sup>. Switch-on and shutdown show up as two distinct phases, each with its own clock.<\/p>\n<p><strong>With the same blister, some people close early and others late.<\/strong> In the early closers, their resolution signals keep rising as the inflammation fades. In the late closers it&#8217;s the reverse: those signals run out while the inflammation keeps going<sup><a href=\"#referencias\">4<\/a><\/sup>.<\/p>\n<p>We don&#8217;t all close the same way. How much we inflame matters, and so does when the order to stop arrives.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_does_the_body_sometimes_not_finish_the_job\"><\/span>Why does the body sometimes not finish the job?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Because the shutdown depends on three parts, and it only takes one of them falling short.<\/strong><\/p>\n<p><strong>The machinery.<\/strong> Closing means clearing up: macrophages have to remove the cells that have done their job. When De Maeyer&#8217;s team in London compared younger and older people with the same blister, <strong>the switch-on was the same, but the shutdown in older people was clearly impaired<\/strong>, because their macrophages cleared up less well<sup><a href=\"#referencias\">5<\/a><\/sup>. When the responsible pathway was corrected with a drug, the older people&#8217;s macrophages went back to clearing almost like the younger ones&#8217;. It&#8217;s a real defect, measured in people, and reversible.<\/p>\n<p><strong>The raw material.<\/strong> Resolvins and protectins, two of the families of signals that direct the shutdown, <strong>are made from omega-3<\/strong>, and they appear right when the body moves from switching on to closing<sup><a href=\"#referencias\">6<\/a><\/sup>. Without EPA and DHA in your membranes, the factory for those signals has nothing to work with.<\/p>\n<p><strong>The conditions.<\/strong> Eating and sleeping at the wrong times, on its own, raises inflammatory markers, and getting back to a routine brings them down.<\/p>\n<table style=\"width:100%;border-collapse:collapse;margin:18px 0;font-size:.97em;\">\n<thead>\n<tr>\n<th style=\"text-align:left;padding:10px 12px;border-bottom:2px solid #0F6E56;color:#004B53;\">Part<\/th>\n<th style=\"text-align:left;padding:10px 12px;border-bottom:2px solid #0F6E56;color:#004B53;\">What it does<\/th>\n<th style=\"text-align:left;padding:10px 12px;border-bottom:2px solid #0F6E56;color:#004B53;\">What&#8217;s been measured in people<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px 12px;border-bottom:1px solid #d7ebe9;\"><strong>The machinery<\/strong><\/td>\n<td style=\"padding:10px 12px;border-bottom:1px solid #d7ebe9;\">Macrophages clear away cells that have done their job<\/td>\n<td style=\"padding:10px 12px;border-bottom:1px solid #d7ebe9;\">With age, switch-on stays the same and the shutdown gets slower<sup><a href=\"#referencias\">5<\/a><\/sup><\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px 12px;border-bottom:1px solid #d7ebe9;\"><strong>The raw material<\/strong><\/td>\n<td style=\"padding:10px 12px;border-bottom:1px solid #d7ebe9;\">Omega-3, which resolvins and protectins are made from<\/td>\n<td style=\"padding:10px 12px;border-bottom:1px solid #d7ebe9;\">Five days of omega-3 raised blood levels of resolvin precursors<sup><a href=\"#referencias\">7<\/a><\/sup><\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px 12px;border-bottom:1px solid #d7ebe9;\"><strong>The conditions<\/strong><\/td>\n<td style=\"padding:10px 12px;border-bottom:1px solid #d7ebe9;\">Timing, sleep and movement<\/td>\n<td style=\"padding:10px 12px;border-bottom:1px solid #d7ebe9;\">Eating and sleeping at the wrong times raises inflammatory markers<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Seen this way, the question changes. It&#8217;s no longer &#8220;how do I switch this off?&#8221; but <strong>&#8220;which of the three parts is falling short for me?&#8221;<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_about_anti-inflammatories\"><\/span>What about anti-inflammatories?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>They do something else: they hold back the switch-on. The shutdown is a separate process.<\/strong><\/p>\n<p>In these same human models, the effect of an anti-inflammatory is defined as <strong>suppressing the switch-on phase<\/strong><sup><a href=\"#referencias\">3<\/a><\/sup>. That&#8217;s useful, and often necessary. But switching on less isn&#8217;t the same as closing, and in animals, the timing of that block changes how the response closes. That story, with its nuances, is in <a href=\"https:\/\/vibefarma.com\/us\/blog\/resolution-interval-inflammation\/\">the resolution window<\/a>.<\/p>\n<p>If you take medication regularly, this is a reason to <strong>bring it to your physician and talk it over<\/strong>: it&#8217;s science from the last two decades, and your physician is where that decision is made.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_happens_when_you_give_your_body_the_raw_material\"><\/span>What happens when you give your body the raw material?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Resolution signals rise measurably, and within days.<\/strong><\/p>\n<p>In healthy people, <strong>five days of omega-3 were enough to raise blood levels of resolvin precursors and some resolvins<\/strong>, though not all of them<sup><a href=\"#referencias\">7<\/a><\/sup>. The raw material reaches the blood quickly.<\/p>\n<p>And it rises right when it&#8217;s needed. <strong>With omega-3, resolution signals \u2014resolvins, lipoxins and their precursors\u2014 rose more than with placebo, peaking two hours after the challenge<\/strong><sup><a href=\"#referencias\">8<\/a><\/sup>.<\/p>\n<p>You can see it in tissue too, not just in blood. In healthy women who took EPA for twelve weeks, <strong>the ratio of omega-6 (arachidonic acid) to EPA in the skin went from 11:1 to 5:1<\/strong>, and with it the signals that tissue makes when challenged changed as well<sup><a href=\"#referencias\">9<\/a><\/sup>. What you eat changes the raw material your body responds with.<\/p>\n<p>And if you also supply the signal one step ahead \u2014SPM precursors, the name for that family of resolution signals\u2014, they rise in the blood within hours<sup><a href=\"#referencias\">10<\/a><\/sup>. How the raw material and the signal fit together is in <a href=\"https:\/\/vibefarma.com\/us\/blog\/omega-3-and-spms-together\/\">omega-3 and SPMs: one builds up, the other is spread out<\/a>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Does_this_replace_what_Im_already_doing\"><\/span>Does this replace what I&#8217;m already doing?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>No. It&#8217;s another layer, and it adds to it.<\/strong><\/p>\n<p>Resolution researchers treat the shutdown as a process of its own, separate from the switch-on<sup><a href=\"#referencias\">11<\/a><\/sup>. Looking after it doesn&#8217;t mean dropping anything you do: it means giving your body what it uses to finish what it started. In practice, that&#8217;s marine omega-3 every day to keep the raw material topped up, and steady timing, sleep and movement for the conditions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Where_to_start\"><\/span>Where to start<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Omega-3 is the substrate your body uses to build its own resolution signals: it supports the body&#8217;s normal resolution process and a healthy inflammatory response.* How the substrate and the signal fit together, and how to take them day to day, is in <a href=\"https:\/\/vibefarma.com\/us\/blog\/omega-3-and-spms-together\/\">omega-3 and SPMs: one builds up, the other is spread out<\/a>.<\/p>\n<p><em>These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_asked_questions\"><\/span>Frequently asked questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_does_inflammation_sometimes_not_resolve\"><\/span>Why does inflammation sometimes not resolve?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Because resolving inflammation is an active process that can fall short. Apart from whatever triggered it still being present, inflammation stays unresolved when the closing mechanisms fall short: the cells that clear up, the signals that order the stop, or the raw material those signals are made from. It can happen whether the response started off very strong or started off weak.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_everyone_resolve_inflammation_the_same_way\"><\/span>Does everyone resolve inflammation the same way?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>No. In studies where healthy volunteers were given the same controlled skin inflammation, some people closed it early and others late, and the difference lay in how their resolution signals developed. With age, on top of that, the switch-on stays the same but the shutdown gets slower.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_body_need_to_close_an_inflammatory_response\"><\/span>What does the body need to close an inflammatory response?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Three things: cells able to clear away what has done its job, signals that order the stop \u2014such as resolvins and protectins, which are made from omega-3\u2014 and conditions that don&#8217;t push the other way, such as steady timing and enough sleep.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_anti-inflammatories_help_close_inflammation\"><\/span>Do anti-inflammatories help close inflammation?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>They act on a different phase: they hold back the switch-on. The shutdown is a separate process your body has to complete on its own. If you take medication regularly, bring what the science of resolution says today to your physician and talk it over.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_taking_omega-3_change_anything_quickly\"><\/span>Does taking omega-3 change anything quickly?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the blood, yes. In healthy people, five days of omega-3 were enough to raise resolvin precursors. Filling your cell membranes takes longer: weeks to start rising and months to settle in.<\/p>\n<h2 id=\"referencias\"><span class=\"ez-toc-section\" id=\"References\"><\/span>References<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol style=\"font-size:.92em;color:#444;\">\n<li>Nathan C, Ding A. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20303877\/\" rel=\"nofollow noopener\" target=\"_blank\">Nonresolving inflammation<\/a>. Cell, 2010;140(6):871-82.<\/li>\n<li>Jenner W, Motwani M, Veighey K, et al. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24603711\/\" rel=\"nofollow noopener\" target=\"_blank\">Characterisation of leukocytes in a human skin blister model of acute inflammation and resolution<\/a>. PLoS One, 2014;9(3):e89375.<\/li>\n<li>Motwani MP, Flint JD, De Maeyer RP, et al. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27499924\/\" rel=\"nofollow noopener\" target=\"_blank\">Novel translational model of resolving inflammation triggered by UV-killed E. coli<\/a>. J Pathol Clin Res, 2016;2(3):154-65.<\/li>\n<li>Morris T, Stables M, Colville-Nash P, et al. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20421472\/\" rel=\"nofollow noopener\" target=\"_blank\">Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways<\/a>. Proc Natl Acad Sci USA, 2010;107(19):8842-7.<\/li>\n<li>De Maeyer RPH, van de Merwe RC, Louie R, et al. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32251403\/\" rel=\"nofollow noopener\" target=\"_blank\">Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly<\/a>. Nat Immunol, 2020;21(6):615-25.<\/li>\n<li>Serhan CN, Savill J. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16369558\/\" rel=\"nofollow noopener\" target=\"_blank\">Resolution of inflammation: the beginning programs the end<\/a>. Nat Immunol, 2005;6(12):1191-7.<\/li>\n<li>Barden A, Mas E, Croft KD, Phillips M, Mori TA. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25187667\/\" rel=\"nofollow noopener\" target=\"_blank\">Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation<\/a>. J Lipid Res, 2014;55(11):2401-7.<\/li>\n<li>Norris PC, Skulas-Ray AC, Riley I, et al. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30575798\/\" rel=\"nofollow noopener\" target=\"_blank\">Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation<\/a>. Sci Rep, 2018;8(1):18050.<\/li>\n<li>Pilkington SM, Rhodes LE, Al-Aasswad NM, Massey KA, Nicolaou A. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24311515\/\" rel=\"nofollow noopener\" target=\"_blank\">Impact of EPA ingestion on COX- and LOX-mediated eicosanoid synthesis in skin with and without a pro-inflammatory UVR challenge \u2014 report of a randomised controlled study in humans<\/a>. Mol Nutr Food Res, 2014;58(3):580-90.<\/li>\n<li>Souza PR, Marques RM, Gomez EA, et al. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31829100\/\" rel=\"nofollow noopener\" target=\"_blank\">Enriched marine oil supplements increase peripheral blood specialized pro-resolving mediators concentrations and reprogram host immune responses: a randomized double-blind placebo-controlled study<\/a>. Circ Res, 2020;126(1):75-90.<\/li>\n<li>Fullerton JN, Gilroy DW. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27020098\/\" rel=\"nofollow noopener\" target=\"_blank\">Resolution of inflammation: a new therapeutic frontier<\/a>. Nat Rev Drug Discov, 2016;15(8):551-67.<\/li>\n<\/ol>\n<hr>\n<div class=\"medical-reviewer\" style=\"background:#F8FDFF;border-left:4px solid #004B53;padding:16px 20px;border-radius:6px;\">\n<p style=\"margin:0 0 6px 0;\"><strong>&#x2714;&#xfe0f; Medical review<\/strong><\/p>\n<p style=\"margin:0;\">This article was reviewed by <strong>Dr. Jorge Oseguera Anguiano<\/strong>, a physician specializing in <strong>functional and pro-resolution medicine<\/strong>, to verify the accuracy of its content.<\/p>\n<\/div>\n<p class=\"vf-fda\">* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.<\/p>\n<\/div>\n<div class=\"vf-ab\">\n<style>\n.vf-ab{--teal:#004B53;--green:#258055;--offwhite:#F8FDFF;--border:#dcebe4;font-family:'Inter Tight',sans-serif;background:var(--offwhite);border:1px solid var(--border);border-radius:16px;padding:28px 30px;margin:38px 0 10px;display:flex;gap:26px;align-items:flex-start}\n.vf-ab *{box-sizing:border-box}\n.vf-ab .ph{flex:0 0 auto;width:104px;height:104px;border-radius:50%;overflow:hidden;background:#e7f0ec}\n.vf-ab .ph img{width:100%;height:100%;object-fit:cover;display:block}\n.vf-ab .eyebrow{font-family:'JetBrains Mono',monospace;font-size:.66rem;letter-spacing:.13em;text-transform:uppercase;color:var(--green);margin-bottom:7px}\n.vf-ab h3{font-family:'Bricolage Grotesque',sans-serif!important;color:var(--teal)!important;font-weight:600!important;font-size:1.3rem!important;margin:0 0 8px!important}\n.vf-ab p{font-size:.97rem;line-height:1.6;color:#40625f;margin:0 0 10px}\n.vf-ab a{color:var(--teal)!important;font-weight:600;text-decoration:none;border-bottom:1px solid rgba(0,75,83,.25)}\n.vf-ab a:hover{color:var(--green)!important}\n@media(max-width:620px){.vf-ab{flex-direction:column;gap:16px}.vf-ab .ph{width:84px;height:84px}}\n<\/style>\n<div class=\"ph\"><img decoding=\"async\" src=\"https:\/\/vibefarma.com\/us\/wp-content\/uploads\/2026\/08\/toni-villar-fundador-pt.webp\" alt=\"Toni Villar, founder of Vibefarma\"><\/div>\n<div>\n<div class=\"eyebrow\">About the author<\/div>\n<h3>Toni Villar<\/h3>\n<p><strong>Founder of Vibefarma.<\/strong> Sixteen years studying the resolution of inflammation &mdash; first as a health educator, then alongside the physicians who apply it in clinic. That path led to a meeting with Dr. Charles Serhan at Harvard Medical School, the researcher who discovered SPMs.<\/p>\n<p>He writes here about what the science actually says, with the sources in plain sight. Every article is medically reviewed before it goes out. <a href=\"\/us\/about\/\">More about Vibefarma &rarr;<\/a><\/p>\n<\/div>\n<\/div>\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": [\n        \"Article\",\n        \"MedicalWebPage\"\n      ],\n      \"@id\": \"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#article\",\n      \"headline\": \"Why does some inflammation never fully resolve?\",\n      \"description\": \"Inflammation that lingers usually isn't too strong: it's a shutdown that falls short. What holds it back, measured in people, and what your body needs.\",\n      \"inLanguage\": \"en-US\",\n      \"datePublished\": \"2026-10-05\",\n      \"dateModified\": \"2026-10-05\",\n      \"lastReviewed\": \"2026-10-05\",\n      \"mainEntityOfPage\": \"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/\",\n      \"image\": \"https:\/\/vibefarma.com\/us\/wp-content\/uploads\/2026\/09\/inflammation-that-never-resolves-cover.png\",\n      \"author\": {\n        \"@id\": \"https:\/\/vibefarma.com\/#toni-villar\"\n      },\n      \"reviewedBy\": {\n        \"@id\": \"https:\/\/vibefarma.com\/#jorge-oseguera\"\n      },\n      \"publisher\": {\n        \"@id\": \"https:\/\/vibefarma.com\/#organization\"\n      },\n      \"about\": [\n        {\n          \"@type\": \"Thing\",\n          \"name\": \"Resolution of inflammation\"\n        },\n        {\n          \"@type\": \"Thing\",\n          \"name\": \"Unresolved inflammation\"\n        },\n        {\n          \"@type\": \"Thing\",\n          \"name\": \"Specialized pro-resolving mediators\"\n        },\n        {\n          \"@type\": \"Thing\",\n          \"name\": \"Omega-3 fatty acids\"\n        },\n        {\n          \"@type\": \"Thing\",\n          \"name\": \"Macrophages\"\n        }\n      ],\n      \"citation\": [\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Nonresolving inflammation\",\n          \"identifier\": \"PMID:20303877\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/20303877\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Characterisation of leukocytes in a human skin blister model of acute inflammation and resolution\",\n          \"identifier\": \"PMID:24603711\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/24603711\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Novel translational model of resolving inflammation triggered by UV-killed E. coli\",\n          \"identifier\": \"PMID:27499924\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/27499924\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways\",\n          \"identifier\": \"PMID:20421472\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/20421472\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly\",\n          \"identifier\": \"PMID:32251403\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/32251403\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Resolution of inflammation: the beginning programs the end\",\n          \"identifier\": \"PMID:16369558\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/16369558\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation\",\n          \"identifier\": \"PMID:25187667\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/25187667\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation\",\n          \"identifier\": \"PMID:30575798\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/30575798\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Impact of EPA ingestion on COX- and LOX-mediated eicosanoid synthesis in skin with and without a pro-inflammatory UVR challenge \u2014 report of a randomised controlled study in humans\",\n          \"identifier\": \"PMID:24311515\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/24311515\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Enriched marine oil supplements increase peripheral blood specialized pro-resolving mediators concentrations and reprogram host immune responses: a randomized double-blind placebo-controlled study\",\n          \"identifier\": \"PMID:31829100\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/31829100\/\"\n        },\n        {\n          \"@type\": \"ScholarlyArticle\",\n          \"name\": \"Resolution of inflammation: a new therapeutic frontier\",\n          \"identifier\": \"PMID:27020098\",\n          \"url\": \"https:\/\/pubmed.ncbi.nlm.nih.gov\/27020098\/\"\n        }\n      ]\n    },\n    {\n      \"@type\": \"BreadcrumbList\",\n      \"@id\": \"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#breadcrumb\",\n      \"itemListElement\": [\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 1,\n          \"name\": \"Home\",\n          \"item\": \"https:\/\/vibefarma.com\/us\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 2,\n          \"name\": \"Blog\",\n          \"item\": \"https:\/\/vibefarma.com\/us\/blog\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 3,\n          \"name\": \"Why does some inflammation never fully resolve?\"\n        }\n      ]\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/vibefarma.com\/#toni-villar\",\n      \"name\": \"Toni Villar\",\n      \"url\": \"https:\/\/vibefarma.com\/sobre-nosotros\/\",\n      \"description\": \"Founder of Vibefarma. Specialist in omega-3, SPMs (specialized pro-resolving mediators) and the resolution of inflammation.\",\n      \"knowsAbout\": [\n        \"Omega-3 fatty acids\",\n        \"EPA and DHA\",\n        \"Specialized pro-resolving mediators\",\n        \"Resolution of inflammation\"\n      ]\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/vibefarma.com\/#jorge-oseguera\",\n      \"name\": \"Dr. Jorge Oseguera Anguiano\",\n      \"jobTitle\": \"Physician \u2014 Functional and Pro-resolution Medicine\",\n      \"sameAs\": \"https:\/\/drjorgeoseguera.com\",\n      \"knowsAbout\": [\n        \"Functional medicine\",\n        \"Resolution of inflammation\",\n        \"Omega-3 fatty acids\"\n      ]\n    },\n    {\n      \"@type\": \"Organization\",\n      \"@id\": \"https:\/\/vibefarma.com\/#organization\",\n      \"name\": \"Vibefarma\",\n      \"url\": \"https:\/\/vibefarma.com\/\",\n      \"sameAs\": [\n        \"https:\/\/www.instagram.com\/vibefarma\",\n        \"https:\/\/www.facebook.com\/vibefarma\",\n        \"https:\/\/www.tiktok.com\/@vibefarma\",\n        \"https:\/\/www.youtube.com\/@Vibefarma\"\n      ]\n    },\n    {\n      \"@type\": \"FAQPage\",\n      \"@id\": \"https:\/\/vibefarma.com\/us\/blog\/inflammation-that-never-resolves\/#faq\",\n      \"mainEntity\": [\n        {\n          \"@type\": \"Question\",\n          \"name\": \"Why does inflammation sometimes not resolve?\",\n          \"acceptedAnswer\": {\n            \"@type\": \"Answer\",\n            \"text\": \"Because resolving inflammation is an active process that can fall short. Apart from whatever triggered it still being present, inflammation stays unresolved when the closing mechanisms fall short: the cells that clear up, the signals that order the stop, or the raw material those signals are made from. It can happen whether the response started off very strong or started off weak.\"\n          }\n        },\n        {\n          \"@type\": \"Question\",\n          \"name\": \"Does everyone resolve inflammation the same way?\",\n          \"acceptedAnswer\": {\n            \"@type\": \"Answer\",\n            \"text\": \"No. In studies where healthy volunteers were given the same controlled skin inflammation, some people closed it early and others late, and the difference lay in how their resolution signals developed. With age, on top of that, the switch-on stays the same but the shutdown gets slower.\"\n          }\n        },\n        {\n          \"@type\": \"Question\",\n          \"name\": \"What does the body need to close an inflammatory response?\",\n          \"acceptedAnswer\": {\n            \"@type\": \"Answer\",\n            \"text\": \"Three things: cells able to clear away what has done its job, signals that order the stop \u2014such as resolvins and protectins, which are made from omega-3\u2014 and conditions that don't push the other way, such as steady timing and enough sleep.\"\n          }\n        },\n        {\n          \"@type\": \"Question\",\n          \"name\": \"Do anti-inflammatories help close inflammation?\",\n          \"acceptedAnswer\": {\n            \"@type\": \"Answer\",\n            \"text\": \"They act on a different phase: they hold back the switch-on. The shutdown is a separate process your body has to complete on its own. If you take medication regularly, bring what the science of resolution says today to your physician and talk it over.\"\n          }\n        },\n        {\n          \"@type\": \"Question\",\n          \"name\": \"Does taking omega-3 change anything quickly?\",\n          \"acceptedAnswer\": {\n            \"@type\": \"Answer\",\n            \"text\": \"In the blood, yes. In healthy people, five days of omega-3 were enough to raise resolvin precursors. Filling your cell membranes takes longer: weeks to start rising and months to settle in.\"\n          }\n        }\n      ]\n    }\n  ]\n}\n<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Inflammation that lingers usually isn&#8217;t inflammation that&#8217;s too strong. It&#8217;s a shutdown that falls short. Your body closes inflammation with a program of its own, and that program can stall halfway.<\/p>\n","protected":false},"author":1,"featured_media":51646,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_daextinma_seo_power":"","_daextinma_enable_ail":"","footnotes":""},"categories":[143],"tags":[],"class_list":["post-51649","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-resolution-of-inflammation"],"_links":{"self":[{"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/posts\/51649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/comments?post=51649"}],"version-history":[{"count":2,"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/posts\/51649\/revisions"}],"predecessor-version":[{"id":51667,"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/posts\/51649\/revisions\/51667"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/media\/51646"}],"wp:attachment":[{"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/media?parent=51649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/categories?post=51649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vibefarma.com\/us\/wp-json\/wp\/v2\/tags?post=51649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}